Profiel
Matthew E.
Colpoys is the founder of Tactiva Therapeutics LLC.
He is currently an Independent Director at NeoDynamics AB, Chief Operating Officer at Efferent Labs, Inc., and President at Galileo Consulting, Inc. Previously, he was the President & Chief Executive Officer at Woodbrook Group Holdings, Inc. from 2008 to 2009.
He received his undergraduate degree from Canisius College.
Actieve functies van Matthew E. Colpoys
| Bedrijven | Functie | Begin |
|---|---|---|
| NEOS AB | Directeur/Bestuurslid | 01-01-2021 |
Efferent Labs, Inc.
Efferent Labs, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotechnology company which focuses on implantable biosensors for life sciences | Operationeel Directeur | - |
Galileo Consulting, Inc. | President | - |
Eerdere bekende functies van Matthew E. Colpoys
| Bedrijven | Functie | Einde |
|---|---|---|
| WOODBROOK GROUP HOLDINGS INC. | President | 07-01-2009 |
Tactiva Therapeutics LLC
Tactiva Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops adoptive cell therapies for cancer treatment | Algemeen Directeur | - |
Opleiding van Matthew E. Colpoys
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Canisius College
Canisius College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Woodbrook Group Holdings, Inc.
Woodbrook Group Holdings, Inc. Investment ManagersFinance Provides financial advisory services | Finance |
NeoDynamics AB
NeoDynamics AB Medical SpecialtiesHealth Technology Develops equipment for diagnosis of breast cancer | Health Technology |
Efferent Labs, Inc.
Efferent Labs, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotechnology company which focuses on implantable biosensors for life sciences | Health Technology |
Tactiva Therapeutics LLC
Tactiva Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops adoptive cell therapies for cancer treatment | Health Technology |
Galileo Consulting, Inc. |
















